Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Apolipoprotein A-1 and post-transplant cardiovascular and graft outcomes after kidney transplantation: a nationwide prospective cohort (KOTRY) study

Non-traditional lipid markers such as apolipoprotein A-1 (ApoA-1) may better capture residual cardiovascular and graft risk after kidney transplantation, but data are limited. We studied 2307 kidney transplant recipients in the nationwide Korean Organ Transplantation Registry with stored serum samples. Outcomes were...

Daseul Huh, Juyeon Park, Y. K. Kee et al. · 0 citations
Open access Oct 2026

Sequential transarterial radioembolization and atezolizumab plus bevacizumab improves survival in advanced hepatocellular carcinoma.

BACKGROUND Yttrium-90 transarterial radioembolization (TARE) combined with immune checkpoint inhibitors has been investigated as a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC); however, evidence supporting its addition to current standard systemic therapy remains limited. We aimed to compa...

Yun-Mi Ko, H. Shin, Moon-Haeng Hur et al. · 0 citations
Open access Oct 2026

Preoperative radioembolization versus chemoembolization and upfront resection for resectable hepatocellular carcinoma beyond the Milan criteria.

BACKGROUND As the role of transarterial radioembolization (TARE) in resectable hepatocellular carcinoma (HCC) beyond Milan criteria remains undefined, this study compared preoperative TARE and chemoembolization (TACE) with primary resection to establish the optimal management strategy. MATERIALS AND METHODS We retros...

Jea-Yong Park, G. Lim, Yun-Mi Ko et al. · 0 citations
Open access Oct 2026

Seroprevalence and Clinical Characteristics of Hepatitis D Virus Infection in Korean Patients with Chronic Hepatitis B, Liver Cirrhosis, and Hepatocellular Carcinoma.

Background/Aims Hepatitis delta virus (HDV) coinfection exacerbates clinical outcomes in chronic hepatitis B (CHB) patients. With emerging HDV-targeted therapeutics, accurate prevalence and clinical impact data are essential. In this study, the seroprevalence, clinical significance, and molecular characteristics of HDV...

Min Kyung Park, Yun-Sook Lim, E. Cho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.